Monalizumab: inhibiting the novel immune checkpoint NKG2A | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Review

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Online download statistics by month:

Online download statistics by month: January 2020 to November 2023

	Abstract	Full	Pdf
Jan 2020	80	80	0
Feb 2020	142	142	0
Mar 2020	239	239	13
Apr 2020	159	159	38
May 2020	582	582	88
Jun 2020	151	151	29
Jul 2020	60	60	18
Aug 2020	84	83	74
Sep 2020	155	155	60
Oct 2020	396	396	273
Nov 2020	249	250	134
Dec 2020	162	162	93
Jan 2021	192	192	92
Feb 2021	147	147	66
Mar 2021	198	198	99
Apr 2021	171	171	76
May 2021	195	195	68
Jun 2021	143	143	68
Jul 2021	120	119	56
Aug 2021	125	125	71
Sep 2021	173	174	62
Oct 2021	160	160	74
Nov 2021	204	204	103
Dec 2021	172	176	77
Jan 2022	114	115	50
Feb 2022	97	105	72
Mar 2022	197	205	90
Apr 2022	219	235	89
May 2022	201	215	114
Jun 2022	172	180	96
Jul 2022	148	155	63
Aug 2022	283	306	104
Sep 2022	470	491	116
Oct 2022	256	264	76
Nov 2022	296	300	108
Dec 2022	185	188	50
Jan 2023	333	341	86
Feb 2023	215	220	71
Mar 2023	225	236	68
Apr 2023	168	170	74
May 2023	148	150	64
Jun 2023	145	145	61
Jul 2023	128	131	69
Aug 2023	146	146	39
Sep 2023	221	225	49
Oct 2023	335	344	60
Nov 2023	350	351	57
Total	9511	9681	3458